Delivery Order SPE2DR25D3018-SPE2DR26FR8TK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Dupixent 300 mg/2 ml pen injections valued at $10,573.44 with an ultimate completion date of November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a firm fixed price ceiling value of $34,044.34 and ultimate completion date of December 5, 2025. This non-set-aside, competitively awarded delivery order represents a standard pharmaceutical procurement under the federal medical supply chain. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $41,205.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dupixent 200 mg/1.14 ml pen injections. The contract, designated as delivery order 4570324637, is set to be completed by December 19, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded without any set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $6,906.62 under firm fixed-price terms. The order is scheduled for completion by December 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside competitive award reflects AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a $7,697.29 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 11, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Dupixent 300 mg/2 mL pen injections valued at $10,619.04 with a completion date of December 4, 2025. This is a firm fixed-price delivery order issued without a set-aside designation, utilizing competitive procurement procedures. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a firm fixed price ceiling value of $15,878.60 and an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a firm fixed price ceiling value of $30,051.63 and an ultimate completion date of November 18, 2025. This non-set-aside, competitively awarded contract represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,543.56 on December 15, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors (2 mL). This firm fixed-price delivery order, with completion targeted for December 16, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $43,236.24 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on November 13, 2025, with completion scheduled for November 14, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D3018Indefinite Delivery Contract
- SPE2DR25D3018-SPE2DR26FR8TKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $4,272.62. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 8, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026. As a leading pharmaceutical distributor supporting federal medical procurement, AmerisourceBergen supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices to military and veteran healthcare systems. The Dupixent supply through this delivery order supports the Defense Health Agency's pharmaceutical needs, reinforcing the contractor's critical role in the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/4/25 |